An Institute Devoted to Translational Biomedical Research
Home | Contact | Links | 简体中文版
  About Us Research Graduate Education Cooperation and Exchange Translational Research System Technology Platforms Faculty and Staff Join Us  
In the news
Introduction of IHS in Immunology
From Immunology to stem cells, searching for new strategies to treat human disease

Introduction of IHS in International Innovation
The world leading research publication
Picture News

The 11th IHS International Elite Forum was Held Successfully on May 26th, 2016
Research Progress
Type I Interferons Exert Anti-tumor Effect via Reversing Immunosuppression Mediated by Mesenchymal Stromal Cells.
Shou P, Chen Q, Jiang J, Xu C, Zhang J, Zheng C, Jiang M, Velletri T, Cao W, Huang Y, Yang Q, Han X, Zhang L, Wei L, Rabson AB, Chin YE, Wang Y, Shi Y.
Oncogene. 2016 Apr 25. doi: 10.1038/onc.2016.128.
Interaction with Pyruvate Kinase M2 Destabilizes Tristetraprolin by Proteasome Degradation and Regulates Cell Proliferation in Breast Cancer.
Huang L, Yu Z, Zhang Z, Ma W, Song S, Huang G.
Sci Rep. 2016 Mar 1;6:22449.
Upcoming Seminars
HEALTH SCIENCES FRONTIERS FORUM: MicroRNA and Translational Control in the Immune System
HEALTH SCIENCES FRONTIERS FORUM: Regulation of Hypoxia-inducible Factor 1 in Human Cancers
News and Events
The 11th IHS International Elite Forum Was Held Successfully in May, 2016
Scientists Revealed That Tumour Cells Could Educate Mesenchymal Stromal Cells to Promote Tumour Development by Secreting Exosomes
The Institute of Health Sciences (IHS), jointly founded in 1999 by Shanghai Institutes for Biological Sciences (SIBS) of the Chinese Academy of Sciences (CAS) and Shanghai Jiao Tong University School of Medicine (SJTUSM), is devoted to translational biomedical research.
Copyright 2002-2016 The Institute of Health Sciences, SIBS, CAS / SJTUSM All Rights Reserved
225 South Chongqing Road, Shanghai, 200025 P.R. China Tel: 86-21-63847798 / 54923254 Fax: 86-21-63852579
Shanghai ICP #05033115